fda glp-1 warning letters september 2025 news Patients taking an experimental oral drug lost significant weight and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other Trends In FDA FY 2025

Some people should not do keto at all

[1] [3] These effects on your body's food processing and energy regulation may contribute to feelings of tiredness, particularly during the initial treatment period

Patients currently using any GLP 1 medication should consult their healthcare provider before making changes as switching between products requires careful dose conversion and monitoring

BMR is different for everyone and is influenced by factors such as age, sex, weight, height, and muscle mass

Our program includes: Comprehensive medical consultation Individualized treatment planning Laboratory review when clinically appropriate Ongoing monitoring and follow-up Medication is prescribed only when deemed appropriate by a licensed healthcare provider

Blogs & News